{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:25:59Z","timestamp":1777479959787,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The advanced hepatocellular carcinoma (HCC), such as the recurrent tumor after liver transplantation (LT), is an obstacle of HCC treatment. The aim of this study was to discover the underlying mechanism of HCC progression caused by non-coding RNAs (ncRNAs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To this end, we investigated the selected patient cohort of matching primary and recurrent HCC after receiving LT. The recurrent tumors after LT were regarded as clinical models of the advanced HCC. Microarrays were used to profile lncRNA and mRNA expression in HCC recurrent and primary tissue samples. The mRNA profile characteristics were analyzed by bioinformatics. Two cell lines, HepG2 and QGY-7703, were used as HCC cell models. The protein-coding potential, length, and subcellular location of the interested lncRNAs were examined by bioinformatics, Northern blot, fluorescent in situ hybridization (FISH), and quantitative RT-PCR (qRT-PCR) assays. HCC cell proliferation was detected by CCK-8, doubling time and proliferation marker gene quantitation assays. DNA replication during the cell cycle was measured by EdU\/PI staining and flow cytometry analyses. Promoter activity was measured using a luciferase reporter assay. Interactions between DNA, RNA, and protein were examined by immunoprecipitation and pull-down assays. The miRNA-target regulation was validated by a fluorescent reporter assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both lncRNA and mRNA profiles exhibited characteristic alterations in the recurrent tumor cells compared with the primary HCC. The mRNA profile in the HCC recurrent tissues, which served as model of advanced HCC, showed an aberrant cell cycle regulation. Two lncRNAs, the highly expressed lncRNA in recurrent HCC (HERH)-1 and HERH-4, were upregulated in the advanced HCC cells. HERH-1\/4 enhanced proliferation and promoted DNA replication and G1-S transition during the cell cycle in HCC cells. HERH-1 interacted with the transcription factor CREB1. CREB1 enhanced cyclin A2 (CCNA2) transcription, depending on HERH-1-CREB1 interaction. HERH-4 acted as an miR-29b\/c sponge to facilitate CCNA2 protein translation through a competing endogenous RNA (ceRNA) pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The oncogenic lncRNA HERH-1\/4 promoted CCNA2 expression at the transcriptional and post-transcriptional levels and accelerated cell cycle progression in HCC cells. The HERH-1-CREB1-CCNA2 and HERH-4-miR-29b\/c-CCNA2 axes served as molecular stimuli for HCC advance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08714-7","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T08:02:54Z","timestamp":1629964974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Tao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenglu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinnv","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"6","key":"8714_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","volume":"9","author":"MC Wallace","year":"2015","unstructured":"Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765\u201379. https:\/\/doi.org\/10.1586\/17474124.2015.1028363.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"8714_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1159\/000438472","volume":"33","author":"RM Critelli","year":"2015","unstructured":"Critelli RM, De Maria N, Villa E. Biology of hepatocellular carcinoma. Dig Dis. 2015;33(5):635\u201341. https:\/\/doi.org\/10.1159\/000438472.","journal-title":"Dig Dis"},{"issue":"34","key":"8714_CR3","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.3748\/wjg.v22.i34.7645","volume":"22","author":"S Colagrande","year":"2016","unstructured":"Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, Marra F. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol. 2016;22(34):7645\u201359. https:\/\/doi.org\/10.3748\/wjg.v22.i34.7645.","journal-title":"World J Gastroenterol"},{"issue":"39","key":"8714_CR4","doi-asserted-by":"publisher","first-page":"11185","DOI":"10.3748\/wjg.v21.i39.11185","volume":"21","author":"N de\u2019angelis","year":"2015","unstructured":"de\u2019angelis N, Landi F, Carra MC, Azoulay D. Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review. World J Gastroenterol. 2015;21(39):11185\u201398. https:\/\/doi.org\/10.3748\/wjg.v21.i39.11185.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"8714_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/MEG.0000000000001448","volume":"31","author":"AL Chagas","year":"2019","unstructured":"Chagas AL, Felga GEG, Diniz MA, Silva RF, Mattos AA, Silva R, et al. Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival. Eur J Gastroenterol Hepatol. 2019;31(9):1148\u201356. https:\/\/doi.org\/10.1097\/MEG.0000000000001448.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"8714_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1177\/2050640619840221","volume":"7","author":"F Foerster","year":"2019","unstructured":"Foerster F, Hoppe-Lotichius M, Vollmar J, Marquardt JU, Weinmann A, Worns MA, et al. Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation Centre. United European Gastroenterol J. 2019;7(6):838\u201349. https:\/\/doi.org\/10.1177\/2050640619840221.","journal-title":"United European Gastroenterol J"},{"issue":"2","key":"8714_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394. https:\/\/doi.org\/10.1038\/nrclinonc.2017.166.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"8714_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrc3261","volume":"12","author":"A Marusyk","year":"2012","unstructured":"Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012;12(5):323\u201334. https:\/\/doi.org\/10.1038\/nrc3261.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8714_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318. https:\/\/doi.org\/10.1038\/nrc.2017.99.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"8714_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1534\/genetics.112.146704","volume":"193","author":"JT Kung","year":"2013","unstructured":"Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651\u201369. https:\/\/doi.org\/10.1534\/genetics.112.146704.","journal-title":"Genetics."},{"issue":"10","key":"8714_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.tig.2017.08.002","volume":"33","author":"A Jandura","year":"2017","unstructured":"Jandura A, Krause HM. The new RNA world: growing evidence for long noncoding RNA functionality. Trends Genet. 2017;33(10):665\u201376. https:\/\/doi.org\/10.1016\/j.tig.2017.08.002.","journal-title":"Trends Genet"},{"issue":"3","key":"8714_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","volume":"15","author":"IM Dykes","year":"2017","unstructured":"Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics. 2017;15(3):177\u201386. https:\/\/doi.org\/10.1016\/j.gpb.2016.12.005.","journal-title":"Genomics Proteomics Bioinformatics."},{"issue":"1","key":"8714_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in Cancer. Genomics Proteomics Bioinformatics. 2016;14(1):42\u201354. https:\/\/doi.org\/10.1016\/j.gpb.2015.09.006.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"5","key":"8714_CR14","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1245\/s10434-011-1581-y","volume":"18","author":"Z Yang","year":"2011","unstructured":"Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 2011;18(5):1243\u201350. https:\/\/doi.org\/10.1245\/s10434-011-1581-y.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"8714_CR15","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s12032-011-0004-z","volume":"29","author":"MC Lai","year":"2012","unstructured":"Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29(3):1810\u20136. https:\/\/doi.org\/10.1007\/s12032-011-0004-z.","journal-title":"Med Oncol"},{"issue":"6","key":"8714_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.21037\/hbsn.2018.10.07","volume":"7","author":"L Wu","year":"2018","unstructured":"Wu L, Yang Z, Zhang J, Xie H, Zhou L, Zheng S. Long noncoding RNA HOTTIP expression predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Hepatobiliary Surg Nutr. 2018;7(6):429\u201339. https:\/\/doi.org\/10.21037\/hbsn.2018.10.07.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"8714_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3\u201311. https:\/\/doi.org\/10.1055\/s-0034-1397344.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"8714_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12920-016-0179-4","volume":"9","author":"QY Xie","year":"2016","unstructured":"Xie QY, Almudevar A, Whitney-Miller CL, Barry CT, McCall MN. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity. BMC Med Genet. 2016;9(1):18. https:\/\/doi.org\/10.1186\/s12920-016-0179-4.","journal-title":"BMC Med Genet"},{"issue":"3","key":"8714_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/tri.12733","volume":"29","author":"J Liese","year":"2016","unstructured":"Liese J, Peveling-Oberhag J, Doering C, Schnitzbauer AA, Herrmann E, Zangos S, et al. A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation. Transpl Int. 2016;29(3):369\u201380. https:\/\/doi.org\/10.1111\/tri.12733.","journal-title":"Transpl Int"},{"issue":"3","key":"8714_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/bjc.2014.621","volume":"112","author":"K Sugimachi","year":"2015","unstructured":"Sugimachi K, Matsumura T, Hirata H, Uchi R, Ueda M, Ueo H, et al. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br J Cancer. 2015;112(3):532\u20138. https:\/\/doi.org\/10.1038\/bjc.2014.621.","journal-title":"Br J Cancer"},{"issue":"15","key":"8714_CR21","doi-asserted-by":"publisher","first-page":"19824","DOI":"10.18632\/oncotarget.7627","volume":"7","author":"KT Ng","year":"2016","unstructured":"Ng KT, Lo CM, Wong N, Li CX, Qi X, Liu XB, et al. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Oncotarget. 2016;7(15):19824\u201339. https:\/\/doi.org\/10.18632\/oncotarget.7627.","journal-title":"Oncotarget."},{"issue":"9","key":"8714_CR22","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/nbt1242","volume":"24","author":"TA Patterson","year":"2006","unstructured":"Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, et al. Performance comparison of one-color and two-color platforms within the MicroArray quality control (MAQC) project. Nat Biotechnol. 2006;24(9):1140\u201350. https:\/\/doi.org\/10.1038\/nbt1242.","journal-title":"Nat Biotechnol"},{"issue":"20","key":"8714_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179. https:\/\/doi.org\/10.1093\/nar\/gni178.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"8714_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Web Server issu","key":"8714_CR25","doi-asserted-by":"publisher","first-page":"W429","DOI":"10.1093\/nar\/gkl333","volume":"34","author":"HY Huang","year":"2006","unstructured":"Huang HY, Chien CH, Jen KH, Huang HD. RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res. 2006;34(Web Server issue):W429\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"8714_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","volume":"18","author":"X Messeguer","year":"2002","unstructured":"Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18(2):333\u20134. https:\/\/doi.org\/10.1093\/bioinformatics\/18.2.333.","journal-title":"Bioinformatics."},{"key":"8714_CR27","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1\u20131.30.33.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"D1","key":"8714_CR28","doi-asserted-by":"publisher","first-page":"D87","DOI":"10.1093\/nar\/gkz1001","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48(D1):D87\u201392. https:\/\/doi.org\/10.1093\/nar\/gkz1001.","journal-title":"Nucleic Acids Res"},{"key":"8714_CR29","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005. https:\/\/doi.org\/10.7554\/eLife.05005.","journal-title":"Elife."},{"issue":"38","key":"8714_CR30","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","volume":"25","author":"C Giacinti","year":"2006","unstructured":"Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. 2006;25(38):5220\u20137. https:\/\/doi.org\/10.1038\/sj.onc.1209615.","journal-title":"Oncogene."},{"issue":"3","key":"8714_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146(3):353\u20138. https:\/\/doi.org\/10.1016\/j.cell.2011.07.014.","journal-title":"Cell."},{"issue":"18","key":"8714_CR32","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1073\/pnas.1222509110","volume":"110","author":"U Ala","year":"2013","unstructured":"Ala U, Karreth FA, Bosia C, Pagnani A, Taulli R, Leopold V, et al. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc Natl Acad Sci U S A. 2013;110(18):7154\u20139. https:\/\/doi.org\/10.1073\/pnas.1222509110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7414","key":"8714_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101\u20138. https:\/\/doi.org\/10.1038\/nature11233.","journal-title":"Nature."},{"issue":"8","key":"8714_CR34","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1172\/JCI84421","volume":"126","author":"JR Evans","year":"2016","unstructured":"Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Invest. 2016;126(8):2775\u201382. https:\/\/doi.org\/10.1172\/JCI84421.","journal-title":"J Clin Invest"},{"issue":"1","key":"8714_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/bib\/bbv031","volume":"17","author":"F Ferre","year":"2016","unstructured":"Ferre F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106\u201316. https:\/\/doi.org\/10.1093\/bib\/bbv031.","journal-title":"Brief Bioinform"},{"issue":"4","key":"8714_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2011.08.027","volume":"44","author":"C Chu","year":"2011","unstructured":"Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell. 2011;44(4):667\u201378. https:\/\/doi.org\/10.1016\/j.molcel.2011.08.027.","journal-title":"Mol Cell"},{"issue":"7483","key":"8714_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352. https:\/\/doi.org\/10.1038\/nature12986.","journal-title":"Nature."},{"issue":"3","key":"8714_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1525","volume":"10","author":"MP Grull","year":"2019","unstructured":"Grull MP, Masse E. Mimicry, deception and competition: the life of competing endogenous RNAs. Wiley Interdiscip Rev RNA. 2019;10(3):e1525. https:\/\/doi.org\/10.1002\/wrna.1525.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"8714_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2007.04.037","volume":"130","author":"SL Ameres","year":"2007","unstructured":"Ameres SL, Martinez J, Schroeder R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell. 2007;130(1):101\u201312. https:\/\/doi.org\/10.1016\/j.cell.2007.04.037.","journal-title":"Cell."},{"issue":"4","key":"8714_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.molcel.2019.06.012","volume":"75","author":"WR Becker","year":"2019","unstructured":"Becker WR, Ober-Reynolds B, Jouravleva K, Jolly SM, Zamore PD, Greenleaf WJ. High-Throughput Analysis Reveals Rules for Target RNA Binding and Cleavage by AGO2. Mol Cell. 2019;75(4):741\u201355.e11.","journal-title":"Mol Cell"},{"issue":"8","key":"8714_CR41","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0006-2952(00)00384-1","volume":"60","author":"JM Blanchard","year":"2000","unstructured":"Blanchard JM. Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1\/S transition by peripheral cues. Biochem Pharmacol. 2000;60(8):1179\u201384. https:\/\/doi.org\/10.1016\/S0006-2952(00)00384-1.","journal-title":"Biochem Pharmacol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T08:03:06Z","timestamp":1629964986000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8714"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08714-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human HCC tissue samples were obtained with the patients\u2019 informed consent and applied in accordance with the Declaration of Helsinki. The ethics approval statements for human subjects were approved by the Ethics Committee of Tianjin First Central Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"957"}}